These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1071 related items for PubMed ID: 16764116

  • 1. Research interactions between industry and academia: a corporate perspective.
    Citron P.
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract] [Full Text] [Related]

  • 2. Principles, property rights, and profits: historical reflections on university/industry relations.
    Kevles DJ.
    Account Res; 2001 Jun; 8(4):293-307. PubMed ID: 12481797
    [No Abstract] [Full Text] [Related]

  • 3. Cementing links between industry and the university.
    Jennings R.
    Nat Biotechnol; 1998 May; 16 Suppl():35-6. PubMed ID: 9591263
    [No Abstract] [Full Text] [Related]

  • 4. Surprise US election results may boost biotech.
    Fox JL.
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract] [Full Text] [Related]

  • 5. Intellectual property issues in a clinical trial: a corporate perspective.
    Fersko RS, Connolly MJ.
    Qual Assur; 1992 Jun; 1(3):237-48. PubMed ID: 1344679
    [No Abstract] [Full Text] [Related]

  • 6. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB.
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract] [Full Text] [Related]

  • 7. Grant proposal reviewer says he would have scored proposal lower due to conflict of interest.
    Maloney DM.
    Hum Res Rep; 2004 Dec; 19(12):8. PubMed ID: 15810180
    [No Abstract] [Full Text] [Related]

  • 8. Researcher said his colleague should have revealed possible conflicts of interest.
    Maloney DM.
    Hum Res Rep; 2005 Jan; 20(1):8. PubMed ID: 15810184
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Financial conflicts of interest in biomedical research: the need to improve the system.
    Wang AT, Montori VM, Murad MH.
    Drug News Perspect; 2010 Nov; 23(9):607-12. PubMed ID: 21152455
    [Abstract] [Full Text] [Related]

  • 11. Companies balk at California's patent rules for stem cell research.
    Keim B.
    Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
    [No Abstract] [Full Text] [Related]

  • 12. Intellectual property and biotechnology: the U.S. internal experience--Part II.
    Brody B.
    Kennedy Inst Ethics J; 2006 Jun; 16(2):105-28. PubMed ID: 17036443
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L.
    Lakartidningen; 2006 Jun; 102(39):2737. PubMed ID: 16245544
    [No Abstract] [Full Text] [Related]

  • 15. Biobusiness on campus: commercialization of university-developed biomedical technologies.
    Dueker KS.
    Food Drug Law J; 1997 Jun; 52(4):453-509. PubMed ID: 10346675
    [No Abstract] [Full Text] [Related]

  • 16. Razing the tollbooths. A call for restricting patents on basic biomedical research.
    Stix G.
    Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bayh-Dole: if we knew then what we know now.
    Boettiger S, Bennett AB.
    Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
    [No Abstract] [Full Text] [Related]

  • 20. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
    Vitiello B, Heiligenstein JH, Riddle MA, Greenhill LL, Fegert JM.
    Biol Psychiatry; 2004 Jul 01; 56(1):3-9. PubMed ID: 15219466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.